a. CDSCO
b. FDA
c. ORA
d. NCTR
a. Center for Drug Evaluation and Research (CDER)
b. Clinical Data Network for Research (CDNR)
c. Office or Regulatory Affairs (ORA)
d. National Center for Toxicological Research (NCTR)
a. True
b. False
a. True
b. False
a. Investigational Review Board
b. International Review Board
c. Institutional Review Board
d. None of these
a. Requirement
b. Responsible
c. Regulation
d. None of the above
a. Failure Mode Effects Analysis
b. Failure Mode Effects and Criticality Analysis
c. Failure Mode Effects and Critical Analysis
d. Failure Mode Effects and Control Analysis
a. At specified time periods.
b. If it is important to change – (not sure)
c. only if changed by investigator
d. After seeking an approval
a. Current
b. Compliance
c. Code
d. Customer
a. Risk Assessment
b. Risk Analysis
c. Risk Reduction
d. Risk Management
a. Process over people
b. People over process
c. Plan over process
d. Plan over people
a. If system is supporting product or process related to Patient Safety.
b. If system is supporting product or process related to Data Integrity and Quality
c. Both the above
d. None of the above
a. The companies that do not market goods and services to EU residents.
b. The major tech companies not storing personal information about citizens in Europe.
c. The data subject, the controller and the processor.
d. All the above
a. Data Protection Officer
b. Data Protective Office
c. Data Preventive Office
d. None of these
a. Predicate Rules
b. Assert Rules
c. Both the options
d. None of these
a. Format Change is allow
b. Content Change is allow
c. Both are allowed
d. None
a. Racial or ethnic origin
b. Political opinions
c. Religious or philosophical beliefs
d. Birthday
a. True
b. False
a. Case Report Form
a. It’s 21 CFR part 11 Compliant
a. True
b. False
a. Code of Federal Regulations
Leave a Comment